Physician profile
Michael Opoku-Darko
NPI 1205480704
$2,176.86
in general payments reported to CMS, 2019-2025
13 companies · $785 in 2025
The $785 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $297 · 2024: $1,095 · 2025: $785.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,483 · Travel and Lodging: $694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,483.32 |
| Travel and Lodging | $693.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,072.47 | 2024-2025 | Intracept |
| Gt Medical Technologies, INC | $571.90 | 2025 | Gammatile |
| Aesculap, INC. | $168.72 | 2023-2024 | Aesculap, M.Blue |
| Medtronic, INC. | $116.10 | 2023 | Synchromedii |
| Biocomposites INC | $94.00 | 2025 | Stimulan |
| Bioventus LLC | $38.21 | 2024 | Bonescalpel & Sonicone (O.R.) |
| Relievant Medsystems, INC. | $18.70 | 2023 | Intracept |
| Monteris Medical Corporation | $18.03 | 2025 | Neuroblate |
| Ucb, INC. | $17.11 | 2024 | Rystiggo |
| Servier Pharmaceuticals LLC | $16.10 | 2025 | |
| Brainlab, INC. | $15.88 | 2025 | Brainlab, INC. |
| Conetic Solutions, INC. | $15.69 | 2025 | |
| Orthofix Medical, INC. | $13.95 | 2023 | Firebird Nxg, Forza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Opoku-Darko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.